Sinew Pharma has over 90 patent applications, with more than 56 already granted. Our new drug patent protection spans over 30 countries, securing market advantages through a complete global strategic layout. From inhibitor applications to liver metabolic enzyme technology platforms, we employ multi-layered and comprehensive patent protection and strategic positioning to effectively extend protection periods.